The following co-pending patent applications are referred to in the following description:
The entire content of each of these applications is hereby incorporated by reference. As disclosed in U.S. Publication No. 2005/0182476, an introducer as shown in the figures has an introducer catheter 3 extending over a guide wire catheter 5. The guide wire catheter 5 extends from the distal end 7 of the introducer 1 to immediately distal of the nose cone dilator 11. A branched stent graft 13 is retained at its proximal end by a retention arrangement (see FIGS. 12 and 13 for one example of a proximal retention arrangement) onto the introducer immediately distal of the nose cone dilator 11. The branched stent graft 13 is retained at its distal end by another retention arrangement (see FIGS. 14 and 15 for examples of a proximal retention arrangement) onto the introducer. A sleeve 15 operated by a sleeve manipulator 17 is mounted on the introducer catheter 3 and in the ready to deploy position the sleeve 15 extends over the branched stent graft 13 to the nose cone dilator 11. As illustrated in FIG. 7, however, the sleeve 15 is withdrawn so that the branched stent graft is exposed to show detail of the assembly. A handle 19 at the distal end of the introducer catheter 3 enables manipulation of the introducer 1.
This invention relates to a medical device and more particularly a device which can be deployed by endovascular means into the vasculature of a patient.
There have been proposed bifurcated endovascular devices which can be deployed into the vasculature, particularly in the region of the aortic bifurcation, so that an aneurysm in the aorta can be bridged by placement of the endovascular device with a proximal portion which seals into a non-aneurysed portion of the aorta adjacent to the renal arteries, a first leg which extends down one iliac artery to a non-aneurysed portion of the iliac artery and another short leg into which a leg extension may be placed to extend into a non-aneurysed portion of the contra-lateral iliac artery.
There can be problems, however, if the aneurysm of the aorta extends down into one or other of the iliac arteries. Each of the common iliac arteries branches into the internal and external iliac arteries and it is necessary in such a situation that a blood flow path can be directed through an endovascular stent graft into each of these arteries.
The object of this invention is to provide a single endovascularly deployed medical device which can solve this problem or at least provide a physician with a useful alternative.
Throughout this specification the term distal with respect to a portion of the aorta, a deployment device or a prosthesis means the end of the aorta, deployment device or prosthesis further away in the direction of blood flow away from the heart and the term proximal means the portion of the aorta, deployment device or end of the prosthesis nearer to the heart. When applied to other vessels similar terms such as caudal and cranial should be understood.
In one form therefore the invention is said to reside in a stent graft comprising a tubular body of a biocompatible graft material defining a main lumen therethrough, a bifurcation in the tubular body at one end thereof and a first leg and a second leg extending from the bifurcation, the first leg being a long leg and the second leg being a short leg, the first and second legs having respective first and second lumens therethrough and the first and second lumens being in fluid communication with the main lumen, characterised by the first long leg comprising a side arm with a side arm lumen therethrough and the side arm lumen being in fluid communication with the first leg lumen, whereby the stent graft can be deployed into the vasculature of a patient with the tubular body being in an aorta of the patient, the first leg extending down an iliac artery, the second leg being directed towards a contralateral iliac artery and the side arm on the first leg directed to an internal artery of the iliac artery.
In one preferred embodiment the side arm comprises a tube of corrugated biocompatible graft material and the tube extends part helically around the first leg.
In an alternative embodiment the side arm comprises a tube of biocompatible graft material and at least one self expanding stent on the tube of biocompatible graft material. Co-pending United States Patent Application Serial No. entitled “ “discloses side arm tubes suitable for the present invention.
Preferably the first leg includes an aperture or fenestration proximally of the side arm and a valve arrangement to prevent fluid flow through the aperture from inside of the leg to outside of the leg.
Preferably the aperture includes a resilient reinforcement ring around the aperture.
The valve arrangement can comprise a sleeve of a biocompatible graft material within the first leg and a self expanding stent within the sleeve, the sleeve being fastened at its proximal end to the first leg proximal of the aperture and the self expanding stent being fastened to the sleeve, whereby the self expanding stent forces the sleeve against the inner surface of the first leg around the aperture to prevent fluid flow through the aperture from inside of the leg to outside of the leg.
In one preferred embodiment the sleeve of a biocompatible graft material comprises a cylindrical form. In an alternative embodiment the sleeve of a biocompatible graft material comprises a semi-cylindrical form.
Alternatively the valve can be formed from a self expanding stent to which a part cylindrical portion of biocompatible graft material is stitched along spaced apart struts of the self expanding stent. These two components together can form a valve assembly which can be stitched into the longer leg of the stent graft.
The valve assembly can further include a semi-circular resilient wire around the distal end of the part cylindrical portion of biocompatible graft material forming the valve member. This semi-circular resilient wire around the distal end of the part cylindrical portion of biocompatible graft material will assist with sealing off the fenestration by ensuring that the distal end of the valve member is held against the inside of the wall of the longer first leg of the stent graft.
The biocompatible graft material can include polytetrafluoroethylene, Dacron, polyamide or any other suitable biocompatible graft material.
While Dacron, expanded polytetrafluoroethylene (ePTFE), or other synthetic biocompatible materials can be used for the tubular graft material for the stent graft, a naturally occurring biomaterial, such as collagen, is highly desirable, particularly a specially derived collagen material known as an extracellular matrix (ECM), such as small intestinal submucosa (SIS). Besides SIS, examples of ECM's include pericardium, stomach submucosa, liver basement membrane, urinary bladder submucosa, tissue mucosa, and dura mater.
SIS is particularly useful, and can be made in the fashion described in Badylak et al., U.S. Pat. No. 4,902,508; Intestinal Collagen Layer described in U.S. Pat. No. 5,733,337 to Carr and in 17 Nature Biotechnology 1083 (Nov. 1999); Cook et al., WIPO Publication WO 98/22158, dated 28 May 1998, which is the published application of PCT/US97/14855, the teachings of which are incorporated herein by reference. Irrespective of the origin of the material (synthetic versus naturally occurring), the material can be made thicker by making multilaminate constructs, for example SIS constructs as described in U.S. Pat. Nos. 5,968,096; 5,955,110; 5,885,619; and 5,711,969. In addition to xenogenic biomaterials, such as SIS, autologous tissue can be harvested as well, for use in forming the tubular graft material. Additionally Elastin or Elastin-Like Polypetides (ELPs) and the like offer potential as a material to fabricate the tubular graft material to form a device with exceptional biocompatibility.
SIS is available from Cook Biotech, West Lafayette, Ind., USA.
It will be seen that by this invention there is provided a stent graft which has a main bifurcation to allow access into each of the iliac arteries and in one of the legs extending from the bifurcation there is a further bifurcation or branch which will enable access into the internal iliac artery. There is some advantage in having a double or twin bifurcation stent graft.
As discussed above there is preferably a valve arrangement proximal of the side arm or side branch of the iliac leg of the bifurcated stent graft. The valve allows an indwelling catheter to be provided through the sidearm in the iliac artery at the time of deployment to assist with deployment of leg extension into the internal iliac artery.
U.S. patent application Ser. No. 10/962,763 entitled “Introducer for Iliac Side Branch Device” discloses an arrangement for using an indwelling catheter to access an internal iliac artery and the teaching of this specification is incorporated herewith in its entirety.
In this case the indwelling catheter can be extended and its guide wire snared from the contra-lateral artery and the leg extension placed into the internal iliac artery before the leg extension is placed into the iliac artery.
In a further form the invention is said to reside in a stent graft comprising a tubular body of a biocompatible graft material defining a main lumen therethrough an aperture defining a fenestration in the tubular body and a valve arrangement to prevent fluid flow through the aperture.
Preferably the aperture includes a resilient reinforcement ring around the aperture.
Preferably the valve arrangement comprises a sleeve of a biocompatible graft material within the tubular body and a self expanding stent within the sleeve, the sleeve being fastened at its proximal end to the first leg proximal of the aperture and the self expanding stent being fastened to the sleeve, whereby the self expanding stent forces the sleeve against the inner surface of the tubular body around the aperture to prevent fluid flow through the aperture.
The sleeve of a biocompatible graft material can comprise a cylindrical form or alternatively a semi-cylindrical form.
In one embodiment the valve arrangement comprises a valve assembly comprising a self expanding stent to which a part cylindrical portion of biocompatible graft material is stitched along spaced apart struts of the self expanding stent.
The valve assembly can further comprise a semi-circular resilient wire around the distal end of the part cylindrical portion of biocompatible graft material forming the valve member.
This then generally describes the invention but to assist with understanding reference will now be made to the accompanying drawings which show further embodiments of the invention.
In the drawings;
Looking more closely at the drawings and in particular
The vasculature comprises an aorta 10 in the region between the renal arteries 12 and the aortic bifurcation 14. Common iliac arteries 16 and 18 extend down from the aortic bifurcation 14. The aorta 10 has an aneurysm 20 which extends down into the common iliac artery 18 as far as the bifurcation 22 between the internal iliac artery 24 and the external iliac artery 26.
To traverse the aneurysm 20 a twin bifurcated aortic stent graft 40 according to one embodiment of the present invention has been deployed into the aorta 10. In this drawing the introduction device which is used to deploy the stent graft into the vasculature has been omitted to assist clarity. In our earlier patent application, PCT Patent Publication No. WO 98/53761 entitled “A prosthesis and a method deploying a prosthesis” there is disclosed an introducer for a stent graft which is suitable for use with the present invention. The proximal end 42 of the bifurcated stent graft 40 is engaged into non-aneurysed portion 28 of the aorta 10 just distal of the renal arteries 12. In this embodiment stent graft 40 has a proximally extending supra-renal exposed stent 44 with barbs 46 engaging the wall of the aorta proximal of the renal arteries to provide a secure position to prevent migration of the stent graft. The stent graft 40 has a short leg 50 and a long leg 52 extending from the graft bifurcation 54. The longer leg 52 has a sealing surface 56 at its distal end which engages into a non-aneurysed portion of the external iliac artery 26.
The longer leg 52 has a side arm 60 which in this embodiment is in the form of a corrugated tube extending in a part helical manner from its connection at a fenestration 62 into the longer leg 52. The side arm 60 extends in a distal direction and helically partly around the longer leg 52 and has a distal end 61 remote from its connection with the longer leg 52 which opens adjacent to the internal iliac artery 24.
A fenestration 64 is placed into the longer leg 52 proximal of the connection of the side arm 60 into the longer leg 52. The fenestration 64 has a valve arrangement within it to close it off as will be discussed with reference to
During deployment of the stent graft into the vasculature of a patient an in-dwelling catheter 66 extends through the side arm 60 and out through the valved fenestration 64. The indwelling catheter includes a guide wire 68.
The extension piece 70 seals into a non-aneurysed portion of the internal iliac artery 24.
The process of deployment of a stent graft according to this embodiment of the invention will be discussed with reference to
In this embodiment the longer leg 52 of the bifurcated stent graft 40 as shown in
Substantially opposite to the fenestration 64 in the tubular longer leg 52 the side arm 60 extends from a fenestration 62 in the tubular longer leg 52.
The vasculature comprises an aorta 10 in the region between the renal arteries 12 and the aortic bifurcation 14. Common iliac arteries 16 and 18 extend down from the aortic bifurcation. The aorta 10 has an aneurysm 20 which extends down into the common iliac artery 18 so far as the bifurcation 22 between the internal iliac artery 24 and the external iliac artery 26.
To traverse the aneurysm a bifurcated aortic stent graft 40 has been deployed into the aorta 10. The proximal end 42 of the bifurcated stent graft 40 is engaged into non-aneurysed portion 28 of the aorta 10 just distal of the renal arteries 12. In this embodiment stent graft 40 has a proximally extending supra-renal exposed stent 44 with barbs 46 engaging the wall of the aorta proximal of the renal arteries to provide a secure position to prevent migration of the stent graft. The stent graft 40 has a short leg 50 and a long leg 52 extending from the graft bifurcation 54. The longer leg 52 has a sealing surface 56 at its distal end which engages into a non-aneurysed portion of the external iliac artery 26.
The longer leg 52 has a side arm 90 which in this embodiment is in the form of a stented tube extending from a fenestration 92 in the longer leg 52. The side arm 90 extends in a distal direction and has an end 94 remote from its connection with the longer leg 52 which opens adjacent to the internal iliac artery 24.
A fenestration 64 is placed into the longer leg 52 proximal of the connection of the side arm 90 into the longer leg 52. The fenestration 64 has a valve arrangement within it to close it off as will be discussed with reference to
During deployment of the stent graft into the vasculature of a patient an in-dwelling catheter 66 extends through the side arm 90 and out through the valved fenestration 64. The indwelling catheter includes a guide wire 68 therethrough.
In this embodiment of valve the longer leg 52 of the bifurcated stent graft 40 as shown in
In this embodiment the longer leg 200 of the bifurcated stent graft 40 (
The self expanding stent 206 has a valve member 212 formed from a piece of biocompatible graft material stitched onto spaced apart struts 208 to provide a part cylindrical surface on the self expanding stent 206 to form a valve assembly 214.
Around the lower circumference of the valve member 212 is a portion of resilient wire 213 retained by stitching 215 to assist with retaining the part circular shape of the valve member to endure good sealing against the inside surface of the tubular body of the longer leg 200.
This valve assembly is stitched into the tubular body of the longer leg 200 by stitching 216 at the bends 210 so that the valve member underlies the fenestration 202 and closes off the fenestration to flow therethrough from inside the longer leg to outside. A cross section of the valve at this stage is shown in
Substantially opposite to the fenestration 202 in the tubular longer leg 200 a side arm 218 extends from a fenestration 220 in the tubular longer leg 200. The side arm 218 is in this embodiment formed from a corrugated graft material.
As the inner cannula or guidewire catheter is shown in at least
Detail of the tubular side arm 106 and valve arrangement 112 are shown in
As shown in
As shown in
The use of and indwelling catheter with a curved tip to facilitate snaring from a contralateral iliac artery is taught in U.S. patent application Ser. No. 11/600,655 entitled ‘Stent Graft Introducer’ and the teaching therein is incorporated herein in its entirety.
As shown in
The sheath 122 of the deployment device 110 is then withdrawn to release the shorter leg 109 of the stent graft 104. This stage is shown in
As shown in
As shown in
As shown in
The stent graft in this embodiment comprises a two piece body with a proximal portion 150 and a distal portion 152 which when joined together into the vasculature of the patient provide a composite stent graft. The proximal portion 150 has the proximally extending suprarenal stents 154 and the distal portion 152 is bifurcated with a shorter leg 156 and longer leg 158. The longer leg 158 has the helical side arm 160 and the valved aperture 162 through which the indwelling catheter 164 extends.
The process of deployment of the stent graft of this embodiment is substantially similar to that shown in
It will be realized that an alternative embodiment access for deployment into the internal iliac artery maybe by a brachial approach and in such case the indwelling catheter in the side arm may extend through the main lumen of the stent graft and the valved aperture may not be necessary in such an embodiment.
Throughout this specification various indications have been given as to the scope of invention but invention not limited to any one of these but may reside in two or more of these combined together. The examples are given for illustration only and not for limitations.
This application is a continuation of U.S. application Ser. No. 11/788,285, filed Apr. 19, 2007, which claims the benefit of the filing date under 35 U.S.C. § 119(e) of Provisional U.S. Patent Application Ser. No. 60/793,282, filed Apr. 19, 2006. All of the foregoing applications are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4501263 | Harbuck | Feb 1985 | A |
4592754 | Gupte et al. | Jun 1986 | A |
4762130 | Fogarty et al. | Aug 1988 | A |
4902508 | Badylak et al. | Feb 1990 | A |
5129910 | Phan et al. | Jul 1992 | A |
5197976 | Herweck et al. | Mar 1993 | A |
5413601 | Keshelava | May 1995 | A |
5522880 | Barone et al. | Jun 1996 | A |
5562724 | Vorwerk et al. | Oct 1996 | A |
5571173 | Parodi | Nov 1996 | A |
5578071 | Parodi | Nov 1996 | A |
5591229 | Parodi | Jan 1997 | A |
5617878 | Taheri | Apr 1997 | A |
5653743 | Martin | Aug 1997 | A |
5693087 | Parodi | Dec 1997 | A |
5711969 | Patel et al. | Jan 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5824040 | Cox et al. | Oct 1998 | A |
5885619 | Patel et al. | Mar 1999 | A |
5921995 | Kleshinski | Jul 1999 | A |
5955110 | Patel et al. | Sep 1999 | A |
5968096 | Whitson et al. | Oct 1999 | A |
5984955 | Wisselink | Nov 1999 | A |
5993481 | Marcade et al. | Nov 1999 | A |
6030414 | Taheri | Feb 2000 | A |
6039754 | Caro | Mar 2000 | A |
6059824 | Taheri | May 2000 | A |
6077296 | Shokoohi et al. | Jun 2000 | A |
6093203 | Uflacker | Jul 2000 | A |
6099558 | White et al. | Aug 2000 | A |
6102940 | Robichon et al. | Aug 2000 | A |
6136022 | Nuñez et al. | Oct 2000 | A |
6152956 | Pierce | Nov 2000 | A |
6187033 | Schmitt et al. | Feb 2001 | B1 |
RE37107 | Wells-Roth | Mar 2001 | E |
6206931 | Cook et al. | Mar 2001 | B1 |
6210429 | Vardi et al. | Apr 2001 | B1 |
6221090 | Wilson | Apr 2001 | B1 |
6221098 | Wilson et al. | Apr 2001 | B1 |
6264682 | Wilson et al. | Jul 2001 | B1 |
6283991 | Cox et al. | Sep 2001 | B1 |
6290731 | Solovay et al. | Sep 2001 | B1 |
6325819 | Pavenik et al. | Dec 2001 | B1 |
6325826 | Vardi et al. | Dec 2001 | B1 |
6334869 | Leonhardt et al. | Jan 2002 | B1 |
6344056 | Dehdashtian | Feb 2002 | B1 |
6358284 | Fearnot et al. | Mar 2002 | B1 |
6361544 | Wilson et al. | Mar 2002 | B1 |
6395018 | Castaneda | May 2002 | B1 |
6409750 | Heyodoh et al. | Jun 2002 | B1 |
6409756 | Murphy | Jun 2002 | B1 |
6409757 | Trout, III et al. | Jun 2002 | B1 |
6428565 | Wisselink | Aug 2002 | B1 |
6478817 | Schmitt et al. | Nov 2002 | B2 |
6482227 | Solovay | Nov 2002 | B1 |
6508836 | Wilson et al. | Jan 2003 | B2 |
6517574 | Chuter | Feb 2003 | B1 |
6520988 | Colombo et al. | Feb 2003 | B1 |
6524335 | Hartley et al. | Feb 2003 | B1 |
6554856 | Doorly et al. | Apr 2003 | B1 |
6579309 | Loos et al. | Jun 2003 | B1 |
6582394 | Reiss et al. | Jun 2003 | B1 |
6585758 | Chouinard et al. | Jul 2003 | B1 |
6599302 | Houser et al. | Jul 2003 | B2 |
6599315 | Wilson | Jul 2003 | B2 |
6641606 | Ouriel et al. | Nov 2003 | B2 |
6645242 | Quinn | Nov 2003 | B1 |
6652567 | Deaton | Nov 2003 | B1 |
6663667 | Dehdashtian et al. | Dec 2003 | B2 |
6669720 | Pierce | Dec 2003 | B1 |
6706062 | Vardi et al. | Mar 2004 | B2 |
6723116 | Taheri | Apr 2004 | B2 |
6733522 | Schmitt et al. | May 2004 | B2 |
6733523 | Shaolian et al. | May 2004 | B2 |
6767358 | Leonhardt et al. | Jul 2004 | B2 |
6773457 | Ivancev et al. | Aug 2004 | B2 |
7105020 | Greenberg et al. | Sep 2006 | B2 |
7232459 | Greenberg et al. | Jun 2007 | B2 |
8012193 | Hartley et al. | Sep 2011 | B2 |
8845708 | Hartley et al. | Sep 2014 | B2 |
20010012962 | Schmitt et al. | Aug 2001 | A1 |
20010027338 | Greenberg | Oct 2001 | A1 |
20010037142 | Stelter et al. | Nov 2001 | A1 |
20020052648 | McGuckin, Jr. et al. | May 2002 | A1 |
20020058984 | Butaric et al. | May 2002 | A1 |
20020058986 | Landau et al. | May 2002 | A1 |
20020058987 | Butaric et al. | May 2002 | A1 |
20020058991 | Schmitt | May 2002 | A1 |
20020058993 | Landau et al. | May 2002 | A1 |
20020082684 | Mishaly | Jun 2002 | A1 |
20020099441 | Dehdashtian | Jul 2002 | A1 |
20020111674 | Chouinard et al. | Aug 2002 | A1 |
20020120327 | Cox et al. | Aug 2002 | A1 |
20020143383 | Parodi | Oct 2002 | A1 |
20020144696 | Sharkawy et al. | Oct 2002 | A1 |
20020151957 | Kerr | Oct 2002 | A1 |
20020156517 | Perouse | Oct 2002 | A1 |
20020156522 | Ivancev et al. | Oct 2002 | A1 |
20020169497 | Wholey et al. | Nov 2002 | A1 |
20020173840 | Brucker et al. | Nov 2002 | A1 |
20020193872 | Trout, III et al. | Dec 2002 | A1 |
20020198585 | Wisselink | Dec 2002 | A1 |
20030009212 | Kerr | Jan 2003 | A1 |
20030033005 | Houser et al. | Feb 2003 | A1 |
20030074050 | Kerr | Apr 2003 | A1 |
20030093145 | Lawrence-Brown et al. | May 2003 | A1 |
20030120333 | Ouriel et al. | Jun 2003 | A1 |
20030130720 | De Palma et al. | Jul 2003 | A1 |
20030130724 | De Palma et al. | Jul 2003 | A1 |
20030195614 | Ryan et al. | Oct 2003 | A1 |
20030199967 | Hartley et al. | Oct 2003 | A1 |
20030199973 | Chuter et al. | Oct 2003 | A1 |
20030204242 | Zarins et al. | Oct 2003 | A1 |
20030204243 | Shiu | Oct 2003 | A1 |
20030220682 | Kujawski | Nov 2003 | A1 |
20030225453 | Murch | Dec 2003 | A1 |
20040034406 | Thramann | Feb 2004 | A1 |
20040044396 | Clerc et al. | Mar 2004 | A1 |
20040059406 | Cully et al. | Mar 2004 | A1 |
20040073288 | Kerr | Apr 2004 | A1 |
20040093078 | Moll et al. | May 2004 | A1 |
20040106972 | Deaton | Jun 2004 | A1 |
20040133266 | Clerc et al. | Jul 2004 | A1 |
20040138737 | Davidons et al. | Jul 2004 | A1 |
20040167607 | Frantzen | Aug 2004 | A1 |
20040193245 | Deem et al. | Sep 2004 | A1 |
20040193254 | Greenberg et al. | Sep 2004 | A1 |
20050059923 | Gamboa | Mar 2005 | A1 |
20050102021 | Osborne | May 2005 | A1 |
20050131517 | Hartley et al. | Jun 2005 | A1 |
20050131519 | Hartley | Jun 2005 | A1 |
20050131525 | Hartley | Jun 2005 | A1 |
20050182476 | Hartley | Aug 2005 | A1 |
20050273155 | Bahler et al. | Dec 2005 | A1 |
20060004433 | Greenberg et al. | Jan 2006 | A1 |
20060095118 | Hartley | May 2006 | A1 |
20060136046 | Hartley et al. | Jun 2006 | A1 |
20060247761 | Greenberg et al. | Nov 2006 | A1 |
20070055346 | Chu et al. | Mar 2007 | A1 |
20070142896 | Anderson et al. | Jun 2007 | A1 |
20070219614 | Hartley | Sep 2007 | A1 |
20070250154 | Greenberg | Oct 2007 | A1 |
20070299499 | Hartley | Dec 2007 | A1 |
20080109065 | Bowe | May 2008 | A1 |
20090043377 | Greenberg et al. | Feb 2009 | A1 |
20100161025 | Kuppurathanam | Jun 2010 | A1 |
20100198328 | Hartley | Aug 2010 | A1 |
20110307048 | Ivancev | Dec 2011 | A1 |
20120221094 | Cunningham | Aug 2012 | A1 |
20140148888 | Barrand | May 2014 | A1 |
20140257464 | Roeder | Sep 2014 | A1 |
20140371838 | Buddery | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
0 461 791 | Jun 1991 | EP |
0 646 365 | Sep 1994 | EP |
0 903 118 | Sep 1994 | EP |
0 903 118 | Sep 1994 | EP |
04-231954 | Aug 1992 | JP |
07-008512 | Jan 1995 | JP |
2000-279532 | Oct 2000 | JP |
2001-503285 | Mar 2001 | JP |
WO 9509585 | Apr 1995 | WO |
WO 9516406 | Jun 1995 | WO |
WO 9521592 | Aug 1995 | WO |
WO 9733532 | Sep 1997 | WO |
WO 9822158 | May 1998 | WO |
WO 9822158 | May 1998 | WO |
WO 9853761 | Dec 1998 | WO |
WO 9913808 | Mar 1999 | WO |
WO 9948441 | Sep 1999 | WO |
WO 0032241 | Jun 2000 | WO |
WO 02067815 | Sep 2002 | WO |
WO 03065933 | Aug 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 03082153 | Oct 2003 | WO |
WO 2004064686 | Aug 2004 | WO |
WO 2004089249 | Oct 2004 | WO |
WO 2004093746 | Nov 2004 | WO |
WO 2006113501 | Oct 2006 | WO |
Entry |
---|
Greenberg et al., “Beyond the Aortic Bifurcation: Branched Endovascular Grafts for Thoracoabdominal and Aortoiliac Aneurysms,” 43 Journal of Vascular Surgery, No. 5, pp. 879-886 (May 2006). |
Greenberg et al., “Endovascular Management of Juxtarenal Aneurysms with Fenestrated Endovascular Grafting,” 39 Journal of Vascular Surgery, No. 2, pp. 279-287 (Feb. 2004). |
Greenberg et al., “Primary Endovascular Repair of Juxtarenal Aneurysms with Fenestrated Endovascular Grafting,” 27 European Journal of Vascular Surgery, pp. 484-491 (2004). |
Huynh et al., “Remodeling of an Acellular Collagen Graft into a Physiologically Responsive Neovessel,” 17 Nature Biotechnology, pp. 1083-1086 (Nov. 1999). |
Examiner's First Report for Australian Application No. 2007240703, dated Aug. 30, 2011, 3 pages. |
Patent Examination Report No. 1 for Australian Application No. 2011250798, dated Jun. 27, 2012, 4 pages. |
Patent Examination Report No. 1 for Australian Application No. 2011250799, dated Jul. 20, 2012, 4 pages. |
Office Action and English translation for Chinese Application No. 200780022712.1, dated Aug. 2, 2010, 8 pages. |
Examination for EP 07755802.1 dated Dec. 28, 2011, 4 pages. |
Communication pursuant to Article 96(2) EPC, dated Sep. 17, 2007, for related European Application No. 04 701 753.8-2310. |
Examination Report for corresponding EP Application No. 07755802.1, dated Feb. 16, 2017, 4 pages. |
Office Action and English translation for Japanese Application No. 2012-178429 dated Aug. 27, 2013, 7 pages. |
Office Action and English translation for Japanese Application No. 2012-178429 dated Jun. 3, 2014, 4 pages. |
International Search Report and Written Opinion of the International Searching Authority for International Application No. PCT/US2009/004124, dated Sep. 30, 2009, 15 pages. |
Office Action from co-pending U.S. Appl. No. 12/174,451, dated Jan. 20, 2010, 6 pages. |
Office Action from co-pending U.S. Appl. No. 12/174,451, dated Jul. 9, 2010, 8 pages. |
Number | Date | Country | |
---|---|---|---|
20170325978 A1 | Nov 2017 | US |
Number | Date | Country | |
---|---|---|---|
60793282 | Apr 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11788285 | Apr 2007 | US |
Child | 15651837 | US |